NCT00145522View on ClinicalTrials.gov

Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women

PHASE4CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Menopause

Interventions

DRUG

17ß-Estradiol/Dydrogesterone

1/5 mg/day for 12 cycles of 28 days

DRUG

Tibolone

2,5 mg/day for 12 cycles of 28 days

Trial Locations (11)

Unknown

Site 8, Ancona

Site 15, Cagliari

Site 4, Catania

Site 9, Florence

Site 10, Milan

Site 11, Milan

Sit 14, Modena

Site 6, Roma

Site 1, Torino

Site 2, Torino

Site 7, Udine

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00145522 - Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women | Biotech Hunter | Biotech Hunter